Hereditary sensory and autonomic neuropathy type VI (HSAN-VI) is a recessive human disease that arises from mutations in the dystonin gene (DST; also known as Bullous pemphigoid antigen 1 gene). A milder form of HSAN-VI was recently described, resulting from loss of a single dystonin isoform (DST-A2). Similarly, mutations in the mouse dystonin gene (Dst) result in severe sensory neuropathy, dystonia musculorum (Dst dt ). Two Dst dt alleles, Dst dt-Tg4 and Dst dt-27J , differ in the severity of disease. The less severe Dst dt-Tg4 mice have disrupted expression of Dst-A1 and -A2 isoforms, while the more severe Dst dt-27J allele affects Dst-A1, -A2 and -A3 isoforms. As dystonin is a cytoskeletal-linker protein, we evaluated microtubule network integrity within sensory neurons from Dst dt-Tg4 and Dst dt-27J mice. There is a significant reduction in tubulin acetylation in Dst dt-27J indicative of microtubule instability and severe microtubule disorganization within sensory axons. However, Dst dt-Tg4 mice have no change in tubulin acetylation, and microtubule organization was only mildly impaired. Thus, microtubule instability is not central to initiation of Dst dt pathogenesis, though it may contribute to disease severity. Maintenance of microtubule stability in Dst dt-Tg4 dorsal root ganglia could be attributed to an upregulation in Dst-A3 expression as a compensation for the absence of Dst-A1 and -A2 in Dst dt-Tg4 sensory neurons. Indeed, knockdown of Dst-A3 in these neurons resulted in a decrease in tubulin acetylation. These findings shed light on the possible compensatory role of dystonin isoforms within HSAN-VI, which might explain the heterogeneity in symptoms within the reported forms of the disease.
Introduction
Dystonin (Dst), also known as bullous pemphigoid antigen 1 (Bpag1), is a massive cytoskeletal-linker protein (>600 kDa) belonging to the spectraplakin family of proteins (1) (2) (3) (4) . Differential expression of Dst isoforms occurs in neuronal, muscular and epithelial tissues. Furthermore, alternative splicing of 5 exons yields 3 major neuronal isoforms: Dst-A1, Dst-A2 and Dst-A3 (5, 6) . While all three isoforms possess central plakin and spectrin repeat domains and a C-terminus microtubule binding domain (MTBD), they are unique in the organization of their N-termini. Dst-A1 possesses two calponin homology repeats that make up a functional actin-binding domain (ABD) (7, 8) . This allows Dst-A1 to participate in crosslinking of actin microfilaments with microtubules (9) . Dst-A2 also possesses an ABD, which is preceded by a transmembrane domain (TMD) (9) . This unique N-terminus localizes Dst-A2 to perinuclear membranes and surrounding microfilaments (9) (10) (11) . Though it has a specific intracellular localization, DST-A2 is involved in many different cellular roles, including microtubule stability, organelle integrity and intracellular transport (12) (13) (14) (15) (16) . Finally, Dst-A3 possesses a putative myristoylation motif (myr) followed by a single calponin homology domain, which dramatically reduces its affinity for actin (6, 7, 10) . It is thought that myristoylation of Dst-A3 allows its localization to the plasma membrane, though its specific function remains unknown (7) .
Hereditary sensory and autonomic neuropathy type VI (HSAN-VI) is the recessive human disease that results from mutations in the DST gene. The disease was first classified in 2012 when three Ashkenazi infants presented with joint contractures, dysautonomias and severe psychomotor retardation, which ultimately led to death before the age of two (17) . It was discovered that these individuals possessed a homozygous frameshift mutation that disrupted the C-terminal MTBD, which is common to all three DST isoforms. More recently, two different compound heterozygous mutations have also been found to result in a non-lethal form of HSAN-VI. All three affected siblings presented with joint deformities, reduced pain and tactile sensation and an array of autonomic irregularities including hypohidrosis, chronic diarrhea and sexual dysfunction. It was determined that their novel mutations only affected the expression of DST-A2 (18) , suggesting the importance of DST-A1 and DST-A3 isoforms.
Similarly, a murine disease known as dystonia musculorum (Dst dt ) also arises due to mutations in the Dst gene. Dst dt mice first present with uncoordinated movements at postnatal day 10. Phenotype then rapidly worsens to include severe ataxia, writhing and twisting of the trunk and eventually death by about 3 weeks of age (19, 20) . In accordance with this, the major cell types affected in Dst dt mice are the dorsal root ganglion (DRG) neurons involved in proprioception. They exhibit axonal swellings, a hallmark of Dst dt , and undergo rapid neurodegeneration (11, 13, (21) (22) (23) arose by a transgene insertion-deletion event that disrupted expression of Dst-A1 and -A2, but left Dst-A3 intact (6, 8, 26 ; Fig. 1 ). They exhibit a milder phenotype and generally live a few days longer than Dst dt-27J mice.
Previous studies have described massive disorganization of the cytoskeleton in the neurons of Dst deficient mice, with the microtubule network showing substantial defects (10, 14, 27, 28) . Work done in our laboratory has also characterized a significant reduction in microtubule stability within Dst dt-27J sensory neurons, with evidence pointing towards Dst-A2 as the major isoform responsible for this (12 
Results

Dst dt pathogenesis is not driven by microtubule instability
Tubulin acetylation (Ac) can be used as an indicator for microtubule stability. This post-translational modification of tubulin occurs on lysine 40 of the alpha-tubulin subunit and marks stability of polymerized microtubules as indicated by their resistance to colchicine and nocodazole treatment (29) (30) (31) . Previous work on Dst dt-27J DRGs reported a reduction in the ratio of Actubulin to total alpha tubulin at the pre-phenotype stage (P4) and phenotype stage (P15) as assessed by enhanced chemiluminescence immunoblot (12) . We first set out to validate these findings using more quantitative fluorescent immunoblotting techniques. We observed a significant reduction in the ratio of Ac-tubulin to alpha-tubulin in phenotype stage (P15) Dst
dt-27J
DRG tissue ( Fig. 2A) . This reduction was further confirmed in a homogenous population of P5 primary sensory neurons grown in culture, suggesting that this pathology precedes disease onset (Fig. 2B) . Fig. S1 ). However, tubulin detyrosination had yet to be assessed in Dst dt-Tg4 sensory neurons. This posttranslational modification involves the proteolytic removal of the C-terminal tyrosine residue on alpha-tubulin subunits within polymerized microtubules (30, 32) . Using the same experimental setup as we did for tubulin acetylation, we assessed the ratio of detyrosinated-tubulin to overall alphatubulin. Both P5 and P15 Dst dt-Tg4 DRGs and sensory neurons had similar detyrosinated-tubulin to alpha-tubulin ratios as WT littermates (Fig. 4A-D and Dst dt-Tg4 axons (Fig. 5) . The lack of any discernable difference could be due to the fact that Dst-A1 is still absent or possibly due to the low levels of the Dst-A2 transgene expressed in DRG tissue (11) . It may even be that differential expression of the transgene in DRGs along the length of the spinal cord contributes to the To put this in perspective, we assessed the relative levels of Dst-A3 expression normally present in P15 WT neural tissues ( Fig. 8I and J) . Unexpectedly, highest levels were observed in the spinal cord, being roughly 12-fold higher than in cerebral cortex or DRGs. This might be indicative of a unique/novel role for Dst-A3 in the spinal cord. In any case, these results help us to gauge the impact of a 50% increase in spinal cord, and a 3-4-fold increase in DRGs as it relates to Dst-A3 expression in Dst dt-Tg4 mice. Furthermore, evaluation of the three neuronal Dst isoforms in P15 WT DRGs reveals that Dst-A3 is expressed at extremely low levels compared to both Dst-A1 and -A2 (Supplementary Material, Fig. S4A and B) . This suggests that Dst-A3 may typically not be as important as the other two isoforms in DRGs. However, upon the loss of Dst-A1 and -A2, a 3-4-fold upregulation in Dst-A3 may have a significant biological effect, further suggesting a compensatory role.
We on a mixed CD1/C57BL6 background (Fig. 8L) scrambled groups (Fig. 9A) . In Dst dt-Tg4 sensory neurons treated with Dst shRNA, Dst-A3 was knocked down by 80% relative to scrambled control (Fig. 9A) . Interestingly, the Dst-A3 knockdown level achieved was comparable to normal physiological levels in WT sensory neurons, thus simply mimicking a loss of the characteristic Dst-A3 overexpression seen in Dst dt-Tg4 DRGs. (Fig. 9B left) , the Dst shRNA-treated Dst dt-Tg4 neurons had little or no tubulin acetylation throughout the neuron soma (Fig. 9B right) . We also observed neurons in the non-transduced (GFP-negative) Dst shRNA-treated Dst dt-Tg4 group that retained a high level of acetylated-tubulin in the soma (Fig. 9B right, to discover differences in their pathologies, it is possible that more differences exist between the two alleles. Identification of these would only stand to help us understand the differences in phenotype and lifespan, and also elucidate a common mechanism of death.
Insights into the role of Dst-A3
Of the three neuronal Dst isoforms, Dst-A3 is the one we know the least about. There is only one previous study that had directly evaluated Dst-A3 (also named BPAG1a3) intracellular localization by use of Flag-tagged constructs. They reported that the Dst-A3 N-terminus contains an myr, which allows this isoform to primarily localize to the plasma membrane (7). However, a prior study had been conducted on the BPAG1n3 isoform (the less abundant intermediate filament binding isoform) also using Flag-tagged constructs containing the N-terminal of this isoform (10) . Since both BPAG1n3 and BPAG1a3 (Dst-A3) possess the same N-terminal sequences and only vary towards the C-terminus (4,6,41), we believe the use of N-terminal BPAG1n3 constructs would likely yield results most relevant to Dst-A3, as it is the more predominantly expressed isoform. Their study had found that the BPAG1n3/Dst-A3 N-terminal constructs localized mainly to microtubules, and this was further validated using N-terminal specific BAPG1n3/Dst-A3 antibodies. The proposed function of this isoform on microtubules was that it conferred stability, since this interaction made microtubules more resistant to nocodazole and colchicine treatment (10 Fig. S4A and B) .
Aside from its N-terminus, Dst-A3 contains the same central plakin domain and C-terminal Gas2-related domain as Dst-A1 and -A2. The plakin domain of Dst has previously been shown to interact with the microtubule stabilizing protein MAP1B (42) . More specifically, MAP1B interaction with Dst-A2 has been shown to maintain tubulin acetylation (12) . It could be that when Dst-A2 is lost, MAP1B preferentially binds to the upregulated Dst-A3 and preserves microtubule stability. Some degree of microtubule stability may also come from direct binding of Dst-A3's Gas2-related domain with microtubules, which has been shown to protect against depolymerization (43) .
Ultimately, overexpression of Dst-A3 is not enough to rescue the defects from loss of Dst-A1 and -A2. Therefore this isoform must have its own unique function within the cell and is not fully redundant to either Dst-A1 or -A2. It appears that Dst-A3 is involved in maintaining microtubule stability, however this may not be its predominant function under normal conditions. It would certainly be interesting to further investigate what role Dst-A3 plays within neurons, and as spinal cord seems to express the highest levels of this isoform ( Fig. 8I and J) , this tissue would be a good starting point for elucidating its quintessential function within neurons.
Dst isoform compensation in HSAN-VI?
It was previously believed that HSAN-VI was a lethal disorder of childhood (17) , however the discovery of novel compound heterozygous mutations in an Italian family in 2017 has proven otherwise (18) . As these patients are ∼40 years of age and were found to only lack the Dst-A2 isoform, we now know that retention of all three neuronal isoforms is not critical to survival. Considering this, we may expect for HSAN-VI to present in a variety of manners, varying in severity depending on the mutation and the isoforms affected. Our findings of Dst-A3 upregulation in Dst dt-Tg4 sensory neurons also lead us to believe that this same mechanism of Dst isoform upregulation is possible in HSAN-VI. This may even be one of the reasons for why a much milder disease presentation is observed in the Italian patients; Dst-A3 and maybe even Dst-A1 might be expressed at much higher levels than normal in attempt to offset and compensate for the lack of Dst-A2. This concept is highly exciting as it could open up a number of different therapeutic options, aimed at altering isoform expression levels opposed to the more challenging route of gene therapy.
Conclusions
Here we have determined that the different Dst alleles do not always have identical pathologies. We have observed that microtubule instability is not causative of Dst dt pathology, however it may be one of the factors that influences how severely the disease presents. Additionally, we have also identified an upregulation of Dst-A3 within Dst dt-Tg4 sensory neurons, indicative of the Dst-A3 isoform taking on a compensatory role in maintenance of microtubule stability when the other neuronal isoforms are lost. Taken together, the work presented here sheds light onto the phenotypic differences observed between different Dst alleles and the underlying genetics that cause them. This is highly relevant to human disease, as DST mutations resulting in HSAN-VI lead to a spectrum of symptoms and longevity. Prior to the discovery of the most recent set of HSAN-VI cases, it was believed that HSAN-VI was lethal before the age of two (17) ; however the more recent patients deficient in only DST-A2 continue to live well into their forties (18) . Given the findings we report here, we might even expect to find that DST-A3 (and even possibly DST-A1) are upregulated in their neuronal tissues, potentially compensating for the normal roles of DST-A2 resulting in milder symptoms and prolonged lifespan. As such, further investigation into the possible compensatory effects of Dst isoforms will be invaluable to our understanding of HSAN-VI and in developing therapies for those affected.
Materials and Methods
Ethics statement
All experimental protocols on mice were approved by the Animal Care Committee of the University of Ottawa. Care and use of experimental mice followed the guidelines of the Canadian Council on Animal Care and the Animals for Research Act.
Animals
The Dst dt-Tg4 mouse line arose from a transgene insertiondeletion that affected the 5 region encoding the ABD specific to DST-A1 and DST-A2 isoforms (8, 24, 26) . For these experiments, all Dst dt-Tg4 mice and their WT littermates were maintained on a CD1 background (except where specifically indicated that they are on a mixed CD1/C57BL6 background). The Dst dt-27J line arose due to spontaneous mutation and was found to express very low levels of the Dst transcript (24) . These mice, along with their WT littermates, are on a C57BL6 genetic background. Genotypes for both lines of mice were determined by PCR amplification of genomic tail DNA, as described in (44) .
The PrP-Dst-A2/PrP-Dst-A2;Dst dt-Tg4 rescue mouse (referred to as PrP;Dst dt-Tg4 mice in the text) is a transgenic mouse which exogenously expresses Dst-A2 under the control of the neuronal PrP on the Dst dt-Tg4 background. These mice are maintained and bred on a mixed CD1/C57BL6 background. The derivation and characterization of these mice have been previously described in (11, 44) .
Primary sensory neuron culture and adenovirus transduction
DRGs from P5 and P15 mice were collected following the protocol previously described in (44) . The individual 1.5 ml microfuge tubes containing DRGs in 1X Hank's Balanced Salt Solution (HBSS; Gibco) were centrifuged at 300 g for 5 min. The HBSS was removed and replaced with 300 μl of prewarmed 1.7 mg/ml papain (Worthington). Tubes were then incubated in a 37 • C water bath for 10 min and centrifuged at 300 g for 5 min. The papain solution was then removed and replaced with 300 μl of 2 mg/ml Collagenase A (Roche). Tubes were once again incubated in a 37 • C water bath for 10 min and centrifuged at 300 g for 5 min. For adenovirus transduction experiments, P15 primary sensory neuron cultures were grown as usual until day five and then transduced with either custom-designed Ad-U6-shRNA(mDST)-CMV-GFP (SignaGen Laboratories) or a scrambled control Ad-U6-shRNA(Scramble)-CMV-GFP (SignaGen Laboratories) at a multiplicity of infection of 450 for both. Transduced sensory neuron cultures were maintained for 72 h, RNA was then collected or coverslips were fixed with 3% paraformaldehyde (PFA) for immunofluorescence analysis.
Immunoblotting
Protein was extracted from primary sensory neuron cultures, and from P5, P15 and P21 DRG tissue by gently homogenizing the samples with 1X RIPA buffer (Sigma-Aldrich) supplemented with 6 μl/ml phenyl methyl sulfonyl fluoride (Sigma-Aldrich). Samples were left on ice for 10 min before centrifugation at 4 • C for 10 min at 12 000 g. Supernatant was then collected, and concentrations were determined by bicinchoninic acid assay (BCA assay; Pierce). Protein samples (10 μg, except where indicated otherwise) were separated by SDS-PAGE in 10% gels. PVDF membranes were incubated overnight at 4 • C in a dilution of Odyssey ® blocking buffer (LI-COR) and primary antibody. The following primary antibodies were used: mouse monoclonal anti-acetylated tubulin antibody (1:40 000; Sigma-Aldrich #T7451), rabbit polyclonal anti-detyrosinated tubulin antibody (1:25 000; Millipore #AB3201), mouse monoclonal anti-alpha tubulin antibody (1:50 000; Calbiochem CP06) and rabbit polyclonal anti-alpha tubulin antibody (1:20 000; Abcam ab18251). Membranes were then washed 3 times with 1X Tris-Buffered Saline and incubated for 1 h at RT in an Odyssey ® blocking buffer (LI-COR) and secondary antibody solution. Infrared dye conjugated (IRDye ® ) secondary antibodies used include goat anti-rabbit 800CW (IgG, 1:10,000; LI-COR; 926-32211), goat antirabbit 680RD (IgG, 1:10,000; LI-COR; 926-68071), goat anti-mouse 800CW (IgG, 1:10,000; LI-COR; 926-32210) and goat anti-mouse 680RD (IgG, 1:10,000; LI-COR; 926-68070). Bands were visualized and quantified using the Odyssey ® CLx infrared imaging system (LI-COR Biosciences). 
Immunohistochemistry
Immunocytochemistry
Transduced P15 primary sensory neuron cultures were fixed on coverslips in 3% PFA for 10 min, and subsequently washed 
TUNEL labeling
Hematoxylin and Eosin staining
Whole cervical, thoracic and lumbar DRGs were extracted from P15 mice and fixed in formalin (Fisher Scientific) at 4 • C for 48 h.
Samples were then transferred to 70% ethanol and stored at 4 • C until processing. DRG samples were processed at the University of Ottawa (Department of Pathology and Laboratory Medicine), where they were set in agarose before embedding in paraffin wax with a LOGOS microwave hybrid tissue processor. Paraffinembedded samples were cut by microtome at a thickness of 4 μm and stained for hematoxylin and eosin using a Leica ST5010 Autostainer XL combined with Leica CV5030 Glass Coverslipper. Stained slides were scanned with a MIRAX MIDI digital slide scanner (Zeiss). Images were acquired using 3DHISTECH Panoramic Viewer 1.15.4 at 20× magnification.
RNA-isolation and RT-PCR analysis
RNA was isolated from P15 DRG, spinal cord and cortex tissues, as well as from primary sensory neuron cultures from P15 mice using the RNeasy ® Mini Kit (Qiagen), as per the manufacturer's protocol. Samples were reverse-transcribed with RT 2 First Strand cDNA synthesis kit (Qiagen) using 1 μg total RNA. For cDNA from P15 tissues, we then further diluted the preparation to a 1 in 5 dilution using RNase-free water (Qiagen). 
Quantitative RT-PCR
Dst-A1/-A2/-A3 primer sets are the same as indicated above. Expression of Dst transcripts was normalized to Ppia and Rps18 (Bio-Rad PrimePCR TM pre-optimized primers) by Ct method. These two gene products were found to have the lowest M value out of a series of different targets tested. Reaction mixtures for these are the same as for Dst as described above. Cycling parameters are the same for each target: (1) denature at 95 • C for 10 min; (2) denature at 95 • C for 10 s; (3) anneal at 60 • C for 30 s; and (4) repeat steps 2-3 for 40 cycles. Runs were amplified using a Bio-Rad CFX96. Each genotype and treatment condition (Dst shRNA or scrambled control) was run as three biological replicates (except where indicated), and all samples were run in technical triplicate, with only those within a range of 0.2 Cq used for analysis.
Transmission electron microscopy
Mice were anesthetized by intraperitoneal injection of tribromomethanol (Avertin) and transcardially perfused with 5 mL of 1X PBS followed by 10 mL of Karnovsky's fixative (4% paraformaldehyde, 2% glutaraldehyde [Sigma-Aldrich] and 0.1 M sodium cacodylate buffer [Electron Microscopy Sciences] in 1X PBS). Dorsal root axons were then extracted and separated according to spinal level (cervical, thoracic and lumbar) and fixed overnight at 4 • C in the same fixative. Following fixation, each root was cut into a straight 1 mm segment. Segments were subsequently washed in 0.1 M sodium cacodylate buffer (Electron Microscopy Sciences) for 1 h at room temperature, and again overnight at room temperature. Segments were post-fixed with 1% osmium tetroxide (Electron Microscopy Sciences) and 1.5% potassium ferrocyanide trihydrate (for myelin staining; Acros Organics) in 0.1 M sodium cacodylate buffer for 1 h at room temperature. Samples were then washed 3 times in 0.2 M sodium cacodylate buffer, pH 7.4, for 15 min each. A second fixation step was performed in 2% glularaldahyde and 0.2 M sodium cacodylate buffer for 1.5 h at room temperature. These were washed 3 times in distilled water for 10 min and then dehydrated twice for 20 min for each step in a graded series of ethanol (Commercial Alcohols) from 30-50-70-85-95% ethanol in water. This was followed by two 30 min washes in 100% ethanol, two 15 min washes in 50% ethanol/50% acetone and two 15 min washes in 100% acetone (Fisher Scientific). Dorsal root axon segments were infiltrated in 30% spurr resin/acetone for 20 min, and once overnight, then in 50% spurr resin/acetone for 6 h and finally in 100% spurr resin (Electron Microscopy Sciences) overnight. Segments remained in 100% spurr resin, which was changed twice a day for 3 days at room temperature. All infiltration steps were performed on a rotator at low speed. Segments were embedded in fresh liquid spurr resin, oriented longitudinally inside the molds and then polymerized overnight at 70 • C. Ultrathin sections (80 nm) were then collected onto 200 mesh copper grids and stained with 2% aqueous uranyl acetate (Electron Microscopy Sciences) and Reynold's lead citrate (sodium citrate [Electron Microscopy Sciences] and lead nitrate [Electron Microscopy Sciences]). Sections were observed under a transmission electron microscope (Hitachi 7100) at 40 000×, 70 000× and 100 000× magnifications. An n = 2-3 was used for all P15 dorsal root axon samples, while an n = 1 was used for P20 and P40 dorsal root axon samples. Approximately 50 micrographs were examined at the cervical, thoracic and lumbar levels for each n.
Horizontal ladder test
The testing apparatus was composed of a 4-sided clear box with a Sony Handycam HDR-CX210 5.3 Megapixel Camcorder placed inside, facing upwards toward a horizontal ladder placed lengthwise along the edges of the box. Pup testing began at P10, with testing occurring every second day until the death of the Dst dt mice. Each pup was placed in the middle of the ladder (rungs spaced 0.5 cm apart) and movements were video recorded throughout a 2 min testing period. Analysis of videos included counting total number of steps by forelimbs and by hindlimbs, as well as the total number of faults (paw falling through the rungs) per forelimb or hindlimb. The data presented is the number of faults normalized to the total number of steps taken (by forelimb or hindlimb 
Statistical analysis
Prism 5.0 GraphPad software was used for all statistical analysis, with the exception of quantitative RT-PCR data. For this we used either CFX software (Bio-Rad) for two-way comparisons, and qbase+3.0 software (Biogazelle) for multiple comparison tests.
All two-way comparisons were done by two-tailed Student's t-test. Multiple comparison tests were done by one-way Analysis of variance (ANOVA), followed by Tukey's post hoc test. P-value < 0.05 was considered statistically significant (shown as * ), while P-value < 0.01 is considered highly statistically significant (shown as * * ).
Supplementary Material
Supplementary Material is available at HMG online.
